Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN FRANCISCO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- John Newell, technical analyst and portfolio manager with Fieldhouse Capital Management, profiles a prospect generator exploring in and around...
-
SAN FRANCISCO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- New oil and gas field discoveries in the U.S. are rare, but a tiny oil and gas exploration company, Torchlight Energy Resources Inc. (TRCH:NASDAQ),...
-
SAN FRANCISCO, July 19, 2018 (GLOBE NEWSWIRE) -- Andrew O'Donnell of Supercharged Stocks discusses a gold exploration company that should start receiving summer drill results shortly. Company...
-
SAN FRANCISCO, June 14, 2018 (GLOBE NEWSWIRE) -- Howard Klein of RK Equities and the "Lithium-ion Bull" newsletter expresses his thoughts on several different segments of the lithium market. ...
-
SAN FRANCISCO, May 09, 2018 (GLOBE NEWSWIRE) -- Advancements in fracking and a rising oil price are putting the Red Cave formation back on the map, and a small-cap energy company is acquiring a...
-
SAN FRANCISCO, May 09, 2018 (GLOBE NEWSWIRE) -- Kerr Mines Inc. (TSX:KER) (OTC:KERMF) (FRA:7AZ1) has been actively exploring bringing the past-producing Copperstone Gold Mine in western Arizona back...
-
SAN FRANCISCO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- StoneCastle Investment Management has a high-growth fund that invests wherever it finds opportunities, and it is bullish on healthcare. In this...
-
SAN FRANCISCO, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Jason Kolbert, an analyst with Maxim Group, described the study, which enables this biotech's device to be used in patients undergoing heart surgery...
-
SAN FRANCISCO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- David Kideckel, an analyst with Beacon Securities Ltd., relayed news from this firm's recent annual meeting, including a private placement with a...
-
Streetwise Reports Examines How 'Exciting' Collaborations Possible for Biotech's 'Flexible' Platform
SAN FRANCISCO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Zacks Small-Cap Research's John Vandermosten discussed the potential for this immunotherapy firm's RNAi compounds in oncology. Included in this...